/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / SeraGene Therapeutics

SeraGene Therapeutics

Vancouver, Canada

SeraGene Therapeutics is a pre-clinical stage biotech company reimagining the treatment of coagulation disorders through innovative RNA and nanomedicine technologies.

Healthcare & Biotech

SeraGene Therapeutics, based in Vancouver, Canada, has 2 investors on file, among them Creative Destruction Lab and Pathway to Cures. Its latest round on record is Round, 20 Nov 2025. Its site was last checked 6 Nov 2026: site answers.

seragenetx.com

Funding

1 round on record
Latest roundRound20 Nov 2025
Since that round1 yearno later round on record
Investors in its rounds11 with a VCinfo profile
Nov 2025RoundLed by Pathway to Cures

Round sizes and total raised are on Fundup AI, our sister product for funding data.

Investors

2 investors on file
InvestorEvidenceType
Creative Destruction LabPortfolio pageAccelerator
Pathway to CuresPage + roundInvestor

More from Creative Destruction Lab

1,552 companies on its checked portfolio

Its portfolio leans to AI & Machine Learning (26%), Healthcare & Biotech (22%), Industrial & Manufacturing (14%).

6degreesThe company develops wearable AI that converts human motion into digit…ARCTORISArctoris provides automated wet lab biology R&D and data generation se…Accipiter BiosciencesAccipiter Biosciences designs and develops protein therapies to addres…Adept MaterialsAdept Materials develops a technology for managing vapor, humidity, an…AegiqAegiq is building fault-tolerant quantum computers by combining determ…

See Creative Destruction Lab's full profile · Who invests alongside it

More from Pathway to Cures

4 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (75%), Media & Entertainment (25%).

Spark BiomedicalSpark Biomedical develops and provides transcutaneous auricular neuros…AfimmuneAfimmune is a drug discovery and development company focused on the de…AnvesanaAnvesana is leveraging RNAseq analysis platform to treat rare genetic …

See Pathway to Cures' full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get SeraGene Therapeutics and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Creative Destruction Lab adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/seragenetx.com/investors

# also
GET /v1/companies/seragenetx.com
GET /v1/companies/seragenetx.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing